99 related articles for article (PubMed ID: 16987072)
21. Reovirus core protein mu2 determines the filamentous morphology of viral inclusion bodies by interacting with and stabilizing microtubules.
Parker JS; Broering TJ; Kim J; Higgins DE; Nibert ML
J Virol; 2002 May; 76(9):4483-96. PubMed ID: 11932414
[TBL] [Abstract][Full Text] [Related]
22. Reovirus mu2 protein determines strain-specific differences in the rate of viral inclusion formation in L929 cells.
Mbisa JL; Becker MM; Zou S; Dermody TS; Brown EG
Virology; 2000 Jun; 272(1):16-26. PubMed ID: 10873745
[TBL] [Abstract][Full Text] [Related]
23. Mammalian reovirus L3 gene sequences and evidence for a distinct amino-terminal region of the lambda1 protein.
Harrison SJ; Farsetta DL; Kim J; Noble S; Broering TJ; Nibert ML
Virology; 1999 May; 258(1):54-64. PubMed ID: 10329567
[TBL] [Abstract][Full Text] [Related]
24. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.
Berry JM; Barnabé N; Coombs KM; Butler M
Biotechnol Bioeng; 1999 Jan; 62(1):12-9. PubMed ID: 10099508
[TBL] [Abstract][Full Text] [Related]
25. JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis.
Danthi P; Hansberger MW; Campbell JA; Forrest JC; Dermody TS
J Virol; 2006 Feb; 80(3):1261-70. PubMed ID: 16415003
[TBL] [Abstract][Full Text] [Related]
26. Thermostability of reovirus disassembly intermediates (ISVPs) correlates with genetic, biochemical, and thermodynamic properties of major surface protein mu1.
Middleton JK; Severson TF; Chandran K; Gillian AL; Yin J; Nibert ML
J Virol; 2002 Feb; 76(3):1051-61. PubMed ID: 11773381
[TBL] [Abstract][Full Text] [Related]
27. Reovirus activates a caspase-independent cell death pathway.
Berger AK; Danthi P
mBio; 2013 May; 4(3):e00178-13. PubMed ID: 23674612
[TBL] [Abstract][Full Text] [Related]
28. Mutations in reovirus outer-capsid protein sigma3 selected during persistent infections of L cells confer resistance to protease inhibitor E64.
Baer GS; Dermody TS
J Virol; 1997 Jul; 71(7):4921-8. PubMed ID: 9188554
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis.
Clarke P; Debiasi RL; Meintzer SM; Robinson BA; Tyler KL
Apoptosis; 2005 May; 10(3):513-24. PubMed ID: 15909114
[TBL] [Abstract][Full Text] [Related]
30. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1.
Tyler KL; Squier MK; Rodgers SE; Schneider BE; Oberhaus SM; Grdina TA; Cohen JJ; Dermody TS
J Virol; 1995 Nov; 69(11):6972-9. PubMed ID: 7474116
[TBL] [Abstract][Full Text] [Related]
31. Genetic mapping of reovirus virulence and organ tropism in severe combined immunodeficient mice: organ-specific virulence genes.
Haller BL; Barkon ML; Vogler GP; Virgin HW
J Virol; 1995 Jan; 69(1):357-64. PubMed ID: 7983730
[TBL] [Abstract][Full Text] [Related]
32. Comparisons of the M1 genome segments and encoded mu2 proteins of different reovirus isolates.
Yin P; Keirstead ND; Broering TJ; Arnold MM; Parker JS; Nibert ML; Coombs KM
Virol J; 2004 Sep; 1():6. PubMed ID: 15507160
[TBL] [Abstract][Full Text] [Related]
33. Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response.
Stewart MJ; Smoak K; Blum MA; Sherry B
J Virol; 2005 Mar; 79(5):2979-87. PubMed ID: 15709018
[TBL] [Abstract][Full Text] [Related]
34. Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.
van Houdt WJ; Smakman N; van den Wollenberg DJ; Emmink BL; Veenendaal LM; van Diest PJ; Hoeben RC; Borel Rinkes IH; Kranenburg O
Cancer Gene Ther; 2008 May; 15(5):284-92. PubMed ID: 18259212
[TBL] [Abstract][Full Text] [Related]
35. Mammalian reovirus nonstructural protein microNS forms large inclusions and colocalizes with reovirus microtubule-associated protein micro2 in transfected cells.
Broering TJ; Parker JS; Joyce PL; Kim J; Nibert ML
J Virol; 2002 Aug; 76(16):8285-97. PubMed ID: 12134034
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action.
Virgin HW; Mann MA; Fields BN; Tyler KL
J Virol; 1991 Dec; 65(12):6772-81. PubMed ID: 1719233
[TBL] [Abstract][Full Text] [Related]
37. The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces.
Helander A; Silvey KJ; Mantis NJ; Hutchings AB; Chandran K; Lucas WT; Nibert ML; Neutra MR
J Virol; 2003 Jul; 77(14):7964-77. PubMed ID: 12829836
[TBL] [Abstract][Full Text] [Related]
38. Mammalian orthoreovirus can exit cells in extracellular vesicles.
Smith SC; Krystofiak E; Ogden KM
bioRxiv; 2023 Aug; ():. PubMed ID: 37693509
[TBL] [Abstract][Full Text] [Related]
39. Comparative proteomic analyses of two reovirus T3D subtypes and comparison to T1L identifies multiple novel proteins in key cellular pathogenic pathways.
Berard AR; Severini A; Coombs KM
Proteomics; 2015 Jun; 15(12):2113-35. PubMed ID: 25900405
[TBL] [Abstract][Full Text] [Related]
40. Infectious entry of reovirus cores into mammalian cells enhanced by transfection.
Jiang J; Coombs KM
J Virol Methods; 2005 Sep; 128(1-2):88-92. PubMed ID: 15904980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
